We must educate our GPs and primary care physicians about these red flags before its too late
Tirzepatide, a dual GIP/GLP-1 receptor agonist, helps regulate appetite and blood sugar but can affect energy levels during the early treatment phase
Latest News Study reveals the hidden toll of sudden cardiac death in type 1 and type 2 diabetes (published on December 7, 2025) New fat-burning diabetes pill protects muscle and appetite (published on December 7, 2025) New Drug Treatment Options for Diabetes (published on August 5, 2025)
As we grow older, or when we are exposed to too much stress and environmental pollution (which is a daily reality for most Indians living in cities), the body's natural glutathione levels start to fall
The external advisers ultimately determined there was enough evidence to conclude that eflornithine hydrochloride (DFMO) boosts event-free survival in pediatric patients with high-risk neuroblastoma